PFE · News · 20260923N

Strategic Portfolio Refocus

PFIZER INC · 2026-09-23 · Importance 31 · Surprise 42

Pfizer is restructuring its commercial model around newer and acquired medicines while reducing exposure to its COVID-19 franchise. Chief International Commercial Officer Alexandre de Germay said spending has been redirected toward selected markets and products. The strategy is intended to offset declining COVID-related demand through growth from newer products and acquired assets.

Key facts

• Pfizer has rebuilt its commercial model around newer and acquired products while reducing exposure to its COVID-19 franchise. source
• Pfizer's growth is coming particularly from the Seagen deal and drugs like Padcev. source